You are here
Award Data
The Award database is continually updated throughout the year. As a result, data for FY24 is not expected to be complete until March, 2025.
Download all SBIR.gov award data either with award abstracts (290MB)
or without award abstracts (65MB).
A data dictionary and additional information is located on the Data Resource Page. Files are refreshed monthly.
The SBIR.gov award data files now contain the required fields to calculate award timeliness for individual awards or for an agency or branch. Additional information on calculating award timeliness is available on the Data Resource Page.
-
Responsible Drinking: Internet-based, Interactive Computer Tailored Intervention
SBC: Pro-Change Behavior Systems, Inc. Topic: NIAAADESCRIPTION (provided by applicant): Excessive alcohol use is associated with a range of serious and costly health, social, and economic consequences at the individual and societal level. This program of research serves as a venue by which to produce and test an innovative, science-based, and cost-effective means to intervene in a private, convenient, and individualized way with employed adults wh ...
SBIR Phase II 2012 Department of Health and Human ServicesNational Institutes of Health -
Point of Care Detection of Respiratory Viruses
SBC: LUCIGEN CORPORATION Topic: NIAIDDESCRIPTION (provided by applicant): Respiratory infections have a significant health and economic impact worldwide. Current test products for the diagnosis of respiratory viral infections such as influenza are inadequate for the timely diagnosis needed for successful implementation of antiviral treatment. Unfortunately a test product that can accurately diagnose common respiratory viruses with hi ...
SBIR Phase II 2012 Department of Health and Human ServicesNational Institutes of Health -
Random Shear Shuttle BAC Libraries for Antimicrobial Discovery from Soil Metageno
SBC: LUCIGEN CORPORATION Topic: NIAIDDESCRIPTION (provided by applicant): 100,000 Americans perish each year due to untreatable bacterial infections. The societal benefits of new antibiotic compounds that are effective against numerous multiple drug resistant pathogens would be significant. The best possible source for new antibiotic structures with potentially novel mechanisms of action is within natural environments, particularly s ...
SBIR Phase II 2012 Department of Health and Human ServicesNational Institutes of Health -
Development of NMUR2 Antagonists as Novel Analgesics
SBC: OMEROS CORPORATION Topic: NIDADESCRIPTION (provided by applicant): Pain affects over 100 million Americans annually. Opioids are the primary drugs that can treat pain. However, these drugs produce severe and unwanted side effects, such as respiratory depression, nausea, constipation and tolerance development (Berde et al, 2008); in addition, they are highly addictive (Koob et al, 1998). There is clearly a large, unmet need for ...
SBIR Phase II 2012 Department of Health and Human ServicesNational Institutes of Health -
Computerized Stage-Matched Intervention for Juvenile Offenders
SBC: Pro-Change Behavior Systems, Inc. Topic: NIDADESCRIPTION (provided by applicant): Juvenile crime imposes enormous costs on victims, on society, and on juvenile offenders themselves. However, research assessing the efficacy of interventions for young offenders show, on average, only small effects on recidivism, substance abuse, and other behavioral outcomes. A major problem with existing interventions is that they tend to neglect individual d ...
SBIR Phase II 2012 Department of Health and Human ServicesNational Institutes of Health -
Overcoming Tramadol Resistance In CYP2D6 Poor Metabolizers
SBC: Syntrix Biosystems, Inc. Topic: NIDADESCRIPTION (provided by applicant): Tramadol is a widely prescribed analgesic, with over 25 million prescriptions and 565 million in retail sales in 2009, making it among the best selling generic drugs. One of the advantages of tramadol over traditionalopioids is its lower risk of opioid dependence, resulting in it having an unscheduled status in the U.S. and other countries. Although its mode ...
SBIR Phase II 2012 Department of Health and Human ServicesNational Institutes of Health -
EpiVax Phase II SBIR: Preclinical studies of Tregitope Delivery and Mechanism of
SBC: EPIVAX, INC. Topic: NIDDKDESCRIPTION (provided by applicant): The goal of this Phase II project is to advance the development of novel tolerance-inducing peptides (Tregitopes) to prevent and/or treat Type 1 diabetes (T1D) by optimizing the clinical delivery vehicle and treatment protocol, and by identifying correlates of efficacy in preparation for Phase 1 clinical trials. More than 13,000 children in the U.S. are diagnos ...
SBIR Phase II 2012 Department of Health and Human ServicesNational Institutes of Health -
A Personal Monitor for Space- and Time-Resolved Measurements of Aerosol Exposure
SBC: ENERTECHNIX, INC. Topic: NIEHSDESCRIPTION (provided by applicant): The proposed project will develop and demonstrate a miniaturized, portable aerosol sampler that will collect a series of time- and location-resolved personal exposure samples for conducting research into the relationships among environmental exposure, genetics and health. It will also develop a bench-top assay unit that will perform colorimetric assays for endo ...
SBIR Phase II 2012 Department of Health and Human ServicesNational Institutes of Health -
Phase Plate Holder for Transmission Electron Microscopy
SBC: HUMMINGBIRD PRECISION MACHINE CO. Topic: NIGMSDESCRIPTION (provided by applicant): At the frontier of biological electron microscopy, there is a strong emphasis on imaging the 3-D structure of cells, organelles, and macromolecules in their native state. This is facilitated by the use of frozen-hydrated specimens which have not been subjected to chemical fixation, dehydration or stains. The resolution is currently limited to about 4 nm by ...
SBIR Phase II 2012 Department of Health and Human ServicesNational Institutes of Health -
Engineered tissue-based, high-throughput compound profiling
SBC: Invivosciences, Inc. Topic: NIGMSDESCRIPTION (provided by applicant): Current NIGMS-SBIR funding supported InvivoSciences LLC's (IVS) launch of several product lines in 2010. IVS generated revenues from the sales of three-dimensional (3D) cell culture tools (MC-8TM and IVS InsertsTM) thatcan grow various hydrogel tissues without any support layers. The culture tools enable Palpator TM and Tissue StretcherTM to stretch the hy ...
SBIR Phase II 2012 Department of Health and Human ServicesNational Institutes of Health